Cargando…
Increased Tumor Intrinsic Growth Potential and Decreased Immune Function Orchestrate the Progression of Lung Adenocarcinoma
BACKGROUND: The overall 5-year survival of lung cancer was reported to be only ~15%, with lung adenocarcinoma (LUAD) as the main pathological subtype. Before developing into invasive stages, LUAD undergoes pre-invasive stages of adenocarcinoma in situ (AIS) and minimally invasive adenocarcinoma (MIA...
Autores principales: | Zhao, Yue, Shang, Jun, Gao, Jian, Han, Han, Gao, Zhendong, Yan, Yueren, Zheng, Qiang, Ye, Ting, Fu, Fangqiu, Deng, Chaoqiang, Ma, Zelin, Zhang, Yang, Zheng, Difan, Zheng, Shanbo, Li, Yuan, Cao, Zhiwei, Shi, Leming, Chen, Haiquan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9283781/ https://www.ncbi.nlm.nih.gov/pubmed/35844495 http://dx.doi.org/10.3389/fimmu.2022.921761 |
Ejemplares similares
-
Systemic immune-inflammation index is a stage-dependent prognostic factor in patients with operable non-small cell lung cancer
por: Fu, Fangqiu, et al.
Publicado: (2021) -
Comprehensive analysis of mutational profile and prognostic significance of complex glandular pattern in lung adenocarcinoma
por: Bai, Jinsong, et al.
Publicado: (2022) -
Prognostic effect of ground-glass opacity in subcentimeter invasive lung adenocarcinoma
por: Bai, Jinsong, et al.
Publicado: (2023) -
Impact of Adjuvant Therapy on Survival in Surgically Resected Limited-Stage Small Cell Lung Cancer
por: Li, Di, et al.
Publicado: (2021) -
Distribution and concordance of PD-L1 expression by routine 22C3 assays in East-Asian patients with non-small cell lung cancer
por: Fu, Fangqiu, et al.
Publicado: (2022)